Actively Recruiting

Phase Not Applicable
Age: 50Years - 90Years
All Genders
ID06077435

Comparative Analysis of AI Software and Conventional Colonoscopy for Enhanced Polyp Detection and Diagnosis: A Randomized Controlled Trial

Led by Sahlgrenska University Hospital · Updated on 2025-11-24

915

Participants Needed

1

Research Sites

13 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to evaluate whether artificial intelligence (AI) can improve the detection and classification of polyps during colonoscopy. The study compares different AI systems to see if they differ in their ability to find polyps and whether missed polyps are benign or malignant. This randomized controlled clinical trial is conducted at several hospital sites with patients undergoing elective colonoscopy. Participants are randomly assigned to receive either a colonoscopy using one of three AI systems—EndoAid, CADEYE, or GI-Genius—or a conventional colonoscopy without AI assistance. During AI-assisted colonoscopy, the AI system is activated during instrument withdrawal to identify and alert the endoscopist about polyps. Two AI systems also provide interpretations regarding the benign or malignant nature of the polyps. After the procedure, questionnaires are completed documenting the findings. During the study, data collected includes patient demographics, medical history, examination details such as polyp number and classification, bowel preparation quality, procedure times, and any complications. Researchers will compare adenoma detection rates and the accuracy of AI polyp characterization against conventional histology. Costs associated with AI-assisted versus conventional colonoscopy will also be assessed. Participation involves one colonoscopy procedure with data recorded during and after the examination.

CONDITIONS

Brief Title

Comparative Analysis of AI Software for Enhanced Polyp Detection and Diagnosis

Who Can Participate

Age: 50Years - 90Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age greater than 50 years
  • Scheduled for elective colonoscopy
Not Eligible

You will not qualify if you...

  • Patient declines to participate in the study
  • Age less than 50 years
  • Unprepared bowel

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Up to 40 minutes

Participants undergo either AI-assisted or conventional colonoscopy to detect and characterize polyps. The AI system, if assigned, is activated during instrument withdrawal to identify and classify polyps. Data on polyp detection, characterization, procedure duration, and costs are collected during the examination.

1 procedure visit (in-person)

Trial Site Locations

Total: 1 location

1

Sahlgrenska University Hospital

Gothenburg, Gothenbburg, Sweden, 41345

Actively Recruiting

Loading map...

Research Team

J

Jonas Varkey, MD, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

DIAGNOSTIC

Number of Arms

4

Similar Trials

Comparison of Remimazolam Besylate and Propofol Sedation Dur...

Colonic Polyp

Actively Recruiting

1 location

Compare the Patient Satisfaction and Effectiveness After Nov...

Colo-rectal Cancer

Actively Recruiting

1 location

Large Polyp Study III: Observational Cohort on Endoscopic Re...

Colonic Polyp

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here